Mettler-Toledo International, Inc. (NYSE:MTD) insider Thomas Caratsch sold 1,350 shares of the company’s stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $578.00, for a total transaction of $780,300.00. Following the transaction, the insider now owns 870 shares in the company, valued at $502,860. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Thomas Caratsch also recently made the following trade(s):

  • On Monday, May 15th, Thomas Caratsch sold 2,000 shares of Mettler-Toledo International stock. The stock was sold at an average price of $557.00, for a total transaction of $1,114,000.00.

Shares of Mettler-Toledo International, Inc. (MTD) traded up 0.40% during trading on Monday, reaching $578.92. 69,563 shares of the company traded hands. Mettler-Toledo International, Inc. has a 12-month low of $386.01 and a 12-month high of $618.13. The company has a 50 day moving average price of $594.32 and a 200 day moving average price of $522.25. The firm has a market capitalization of $14.86 billion, a price-to-earnings ratio of 35.60 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, July 27th. The medical instruments supplier reported $3.92 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.89 by $0.03. Mettler-Toledo International had a net margin of 16.60% and a return on equity of 95.28%. The firm had revenue of $653.70 million for the quarter, compared to analyst estimates of $646.68 million. During the same period in the previous year, the firm posted $3.22 EPS. The company’s revenue for the quarter was up 7.5% compared to the same quarter last year. On average, equities analysts predict that Mettler-Toledo International, Inc. will post $16.95 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/08/07/mettler-toledo-international-inc-mtd-insider-thomas-caratsch-sells-1350-shares.html.

Several equities analysts recently weighed in on MTD shares. Cleveland Research upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating in a report on Wednesday, April 19th. Zacks Investment Research upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $538.00 price objective on the stock in a report on Wednesday, April 12th. Bank of America Corporation increased their price objective on shares of Mettler-Toledo International from $590.00 to $630.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. BidaskClub lowered shares of Mettler-Toledo International from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $565.00 price objective (up from $533.00) on shares of Mettler-Toledo International in a report on Saturday, July 22nd. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $569.80.

Hedge funds and other institutional investors have recently modified their holdings of the company. Victory Capital Management Inc. increased its position in shares of Mettler-Toledo International by 16.8% in the second quarter. Victory Capital Management Inc. now owns 3,973 shares of the medical instruments supplier’s stock worth $2,338,000 after buying an additional 572 shares during the period. Federated Investors Inc. PA increased its position in shares of Mettler-Toledo International by 3,722.1% in the second quarter. Federated Investors Inc. PA now owns 18,690 shares of the medical instruments supplier’s stock worth $11,000,000 after buying an additional 18,201 shares during the period. Tocqueville Asset Management L.P. increased its position in shares of Mettler-Toledo International by 40.4% in the second quarter. Tocqueville Asset Management L.P. now owns 702 shares of the medical instruments supplier’s stock worth $413,000 after buying an additional 202 shares during the period. Cadence Capital Management LLC increased its position in shares of Mettler-Toledo International by 1.6% in the second quarter. Cadence Capital Management LLC now owns 2,880 shares of the medical instruments supplier’s stock worth $1,695,000 after buying an additional 45 shares during the period. Finally, Columbus Circle Investors increased its position in shares of Mettler-Toledo International by 1.1% in the second quarter. Columbus Circle Investors now owns 37,440 shares of the medical instruments supplier’s stock worth $22,035,000 after buying an additional 405 shares during the period. Hedge funds and other institutional investors own 96.22% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Insider Buying and Selling by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.